Pressure effects on the growth of human scar fibroblasts

Liang W. Chang, Win Ping Deng, Eng Kean Yeong, Ching Yuan Wu, Shih W. Yeh

研究成果: 雜誌貢獻文章

19 引文 (Scopus)

摘要

Although pressure therapy is the mainstay of treatment for hypertrophic scars, its actual mechanism remains unknown. An in vitro study was designed to investigate the effects of positive pressure on the growth of human scar-derived fibroblasts through its transforming growth factor β1 (TGF-β1) secretion. A pneumatic pressure system connecting to a cell culture chamber was designed. Six-well cultured plates with fibroblasts implanted were treated with different pressure settings. Cells were treated with constant pressure 20 mm Hg above atmosphere pressure (group A n = 18) or with 40 mm Hg above atmosphere pressure (group B n = 18) daily for nine successive days. Cells without pressure were treated as the control study (group C n = 6). Each experimental group was divided into daily pressure applied at 24 hours (n = 6), 18 hours (n = 6), and 12 hours (n = 6). Cell counting was performed on the 2nd, 4th, 7th, 9th, 11th, and 14th day after implantation. On day 4, the concentration of transforming growth factor β1 was measured, and cell doubling time was calculated. Compared with the control group, there was a significant decrease in cell count and the concentration in the 18-hour and 24-hour 20 mm Hg or 40 mm Hg pressure treated group. The cell doubling time was significandy increased in the 24-hour 20 mm Hg or 40 mm Hg pressure treated groups, and the 18-hour 40 mm Hg pressure treated group. (P <.05) Pressure inhibits the growth and activity of human scar fibroblasts, and a higher pressure application can shorten the daily application period. There should be an optimal pressure level corresponding to a daily application period to achieve the most effective results on pressure therapy for scars.

原文英語
頁(從 - 到)835-841
頁數7
期刊Journal of Burn Care and Research
29
發行號5
DOIs
出版狀態已發佈 - 九月 2008

指紋

Cicatrix
Fibroblasts
Pressure
Growth
Transforming Growth Factors
Atmosphere
Hypertrophic Cicatrix
Control Groups
Human Activities
Cell Culture Techniques
Cell Count

ASJC Scopus subject areas

  • Emergency Medicine
  • Rehabilitation
  • Surgery

引用此文

Pressure effects on the growth of human scar fibroblasts. / Chang, Liang W.; Deng, Win Ping; Yeong, Eng Kean; Wu, Ching Yuan; Yeh, Shih W.

於: Journal of Burn Care and Research, 卷 29, 編號 5, 09.2008, p. 835-841.

研究成果: 雜誌貢獻文章

Chang, Liang W. ; Deng, Win Ping ; Yeong, Eng Kean ; Wu, Ching Yuan ; Yeh, Shih W. / Pressure effects on the growth of human scar fibroblasts. 於: Journal of Burn Care and Research. 2008 ; 卷 29, 編號 5. 頁 835-841.
@article{b573e5ac3355474d9f369e082bc76a77,
title = "Pressure effects on the growth of human scar fibroblasts",
abstract = "Although pressure therapy is the mainstay of treatment for hypertrophic scars, its actual mechanism remains unknown. An in vitro study was designed to investigate the effects of positive pressure on the growth of human scar-derived fibroblasts through its transforming growth factor β1 (TGF-β1) secretion. A pneumatic pressure system connecting to a cell culture chamber was designed. Six-well cultured plates with fibroblasts implanted were treated with different pressure settings. Cells were treated with constant pressure 20 mm Hg above atmosphere pressure (group A n = 18) or with 40 mm Hg above atmosphere pressure (group B n = 18) daily for nine successive days. Cells without pressure were treated as the control study (group C n = 6). Each experimental group was divided into daily pressure applied at 24 hours (n = 6), 18 hours (n = 6), and 12 hours (n = 6). Cell counting was performed on the 2nd, 4th, 7th, 9th, 11th, and 14th day after implantation. On day 4, the concentration of transforming growth factor β1 was measured, and cell doubling time was calculated. Compared with the control group, there was a significant decrease in cell count and the concentration in the 18-hour and 24-hour 20 mm Hg or 40 mm Hg pressure treated group. The cell doubling time was significandy increased in the 24-hour 20 mm Hg or 40 mm Hg pressure treated groups, and the 18-hour 40 mm Hg pressure treated group. (P <.05) Pressure inhibits the growth and activity of human scar fibroblasts, and a higher pressure application can shorten the daily application period. There should be an optimal pressure level corresponding to a daily application period to achieve the most effective results on pressure therapy for scars.",
author = "Chang, {Liang W.} and Deng, {Win Ping} and Yeong, {Eng Kean} and Wu, {Ching Yuan} and Yeh, {Shih W.}",
year = "2008",
month = "9",
doi = "10.1097/BCR.0b013e3181848c1c",
language = "English",
volume = "29",
pages = "835--841",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Pressure effects on the growth of human scar fibroblasts

AU - Chang, Liang W.

AU - Deng, Win Ping

AU - Yeong, Eng Kean

AU - Wu, Ching Yuan

AU - Yeh, Shih W.

PY - 2008/9

Y1 - 2008/9

N2 - Although pressure therapy is the mainstay of treatment for hypertrophic scars, its actual mechanism remains unknown. An in vitro study was designed to investigate the effects of positive pressure on the growth of human scar-derived fibroblasts through its transforming growth factor β1 (TGF-β1) secretion. A pneumatic pressure system connecting to a cell culture chamber was designed. Six-well cultured plates with fibroblasts implanted were treated with different pressure settings. Cells were treated with constant pressure 20 mm Hg above atmosphere pressure (group A n = 18) or with 40 mm Hg above atmosphere pressure (group B n = 18) daily for nine successive days. Cells without pressure were treated as the control study (group C n = 6). Each experimental group was divided into daily pressure applied at 24 hours (n = 6), 18 hours (n = 6), and 12 hours (n = 6). Cell counting was performed on the 2nd, 4th, 7th, 9th, 11th, and 14th day after implantation. On day 4, the concentration of transforming growth factor β1 was measured, and cell doubling time was calculated. Compared with the control group, there was a significant decrease in cell count and the concentration in the 18-hour and 24-hour 20 mm Hg or 40 mm Hg pressure treated group. The cell doubling time was significandy increased in the 24-hour 20 mm Hg or 40 mm Hg pressure treated groups, and the 18-hour 40 mm Hg pressure treated group. (P <.05) Pressure inhibits the growth and activity of human scar fibroblasts, and a higher pressure application can shorten the daily application period. There should be an optimal pressure level corresponding to a daily application period to achieve the most effective results on pressure therapy for scars.

AB - Although pressure therapy is the mainstay of treatment for hypertrophic scars, its actual mechanism remains unknown. An in vitro study was designed to investigate the effects of positive pressure on the growth of human scar-derived fibroblasts through its transforming growth factor β1 (TGF-β1) secretion. A pneumatic pressure system connecting to a cell culture chamber was designed. Six-well cultured plates with fibroblasts implanted were treated with different pressure settings. Cells were treated with constant pressure 20 mm Hg above atmosphere pressure (group A n = 18) or with 40 mm Hg above atmosphere pressure (group B n = 18) daily for nine successive days. Cells without pressure were treated as the control study (group C n = 6). Each experimental group was divided into daily pressure applied at 24 hours (n = 6), 18 hours (n = 6), and 12 hours (n = 6). Cell counting was performed on the 2nd, 4th, 7th, 9th, 11th, and 14th day after implantation. On day 4, the concentration of transforming growth factor β1 was measured, and cell doubling time was calculated. Compared with the control group, there was a significant decrease in cell count and the concentration in the 18-hour and 24-hour 20 mm Hg or 40 mm Hg pressure treated group. The cell doubling time was significandy increased in the 24-hour 20 mm Hg or 40 mm Hg pressure treated groups, and the 18-hour 40 mm Hg pressure treated group. (P <.05) Pressure inhibits the growth and activity of human scar fibroblasts, and a higher pressure application can shorten the daily application period. There should be an optimal pressure level corresponding to a daily application period to achieve the most effective results on pressure therapy for scars.

UR - http://www.scopus.com/inward/record.url?scp=55249106694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249106694&partnerID=8YFLogxK

U2 - 10.1097/BCR.0b013e3181848c1c

DO - 10.1097/BCR.0b013e3181848c1c

M3 - Article

VL - 29

SP - 835

EP - 841

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 5

ER -